trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

References related to genes published in Others

PMID	Journal	Published Date	Author	Title
21521824	J. Lipid Res.	2011	Zhao C et al.	TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines.
19864456	Mol. Biol. Cell	2009	Malchinkhuu E et al.	Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells.
15716590	J. Lipid Res.	2005	Budnik LT and Brunswig-Spickenheier B	Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor.
15933052	Blood	2005	Baumforth KR et al.	Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells.
16497989	Arterioscler. Thromb. Vasc. Biol.	2006	Cui MZ et al.	Lysophosphatidic acid induces early growth response gene 1 expression in vascular smooth muscle cells: CRE and SRE mediate the transcription.
9857194	EMBO J.	1998	Ciana P et al.	Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
10200307	Proc. Natl. Acad. Sci. U.S.A.	1999	Saito A et al.	A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors.
10521394	Genes Dev.	1999	Murphy M et al.	Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.
10453011	J. Immunol.	1999	Zabel MD et al.	Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation.
11159758	Carcinogenesis	2001	Kamitani H et al.	Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma.
11577001	Carcinogenesis	2001	Leng SL et al.	Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo.
11557515	Am. J. Physiol. Gastrointest. Liver Physiol.	2001	Kiela PR et al.	Regulation of the rat NHE3 gene promoter by sodium butyrate.
11861904	Nucleic Acids Res.	2002	Drewell RA et al.	Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
11830487	Blood	2002	Zhou DC et al.	Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo.
11290786	J. Immunol.	2001	Bachl J et al.	Increased transcription levels induce higher mutation rates in a hypermutating cell line.
11208539	Am. J. Physiol. Gastrointest. Liver Physiol.	2001	Yang H et al.	Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.
12114433	Clin. Cancer Res.	2002	Toyooka S et al.	Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.
12136092	Nucleic Acids Res.	2002	Fang D et al.	Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
12138131	J. Am. Soc. Nephrol.	2002	Yu Z et al.	Histone deacetylases augment cytokine induction of the iNOS gene.
12177302	Nucleic Acids Res.	2002	Aapola U et al.	Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity.
11948134	Clin. Cancer Res.	2002	Chang TH and Szabo E	Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
11988486	Circ. Res.	2002	Qiu P and Li L	Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression.
12087179	Nucleic Acids Res.	2002	Chen Y et al.	On the epigenetic regulation of the human reelin promoter.
12368351	J. Virol.	2002	Quivy V et al.	Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
12393499	Blood	2003	Witt O et al.	Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.
12626711	Nucleic Acids Res.	2003	Camarero N et al.	Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
12799440	Nucleic Acids Res.	2003	Ferguson M et al.	Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.
12646489	Biol. Reprod.	2003	Shi W et al.	Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos.
12782737	Plant Cell	2003	Chua YL et al.	The transcriptional enhancer of the pea plastocyanin gene associates with the nuclear matrix and regulates gene expression through histone acetylation.
12953060	J. Cell. Sci.	2003	Nakano M et al.	Epigenetic assembly of centromeric chromatin at ectopic alpha-satellite sites on human chromosomes.
12954772	Nucleic Acids Res.	2003	Kim EJ et al.	Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
12972566	Mol. Biol. Cell	2003	Cimini D et al.	Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects.
12975486	J. Pharmacol. Exp. Ther.	2003	Hu E et al.	Identification of novel isoform-selective inhibitors within class I histone deacetylases.
12748129	Biol. Reprod.	2003	Enright BP et al.	Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine.
12711682	Nucleic Acids Res.	2003	Valenta T et al.	HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
12560555	Science	2003	Cheutin T et al.	Maintenance of stable heterochromatin domains by dynamic HP1 binding.
12589032	Mol. Cancer Ther.	2003	Glaser KB et al.	Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.
12433992	Nucleic Acids Res.	2002	Yáñez RJ and Porter AC	A chromosomal position effect on gene targeting in human cells.
10618426	Proc. Natl. Acad. Sci. U.S.A.	2000	Chen WY and Townes TM	Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation.
10841572	Proc. Natl. Acad. Sci. U.S.A.	2000	Jin S et al.	Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation.
15308471	Am. J. Physiol. Gastrointest. Liver Physiol.	2004	Gaudier E et al.	Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose.
15226411	Nucleic Acids Res.	2004	Mao DY et al.	Promoter-binding and repression of PDGFRB by c-Myc are separable activities.
15197237	J. Leukoc. Biol.	2004	Moldenhauer A et al.	Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
15084747	Proc. Natl. Acad. Sci. U.S.A.	2004	Amor DJ et al.	Human centromere repositioning "in progress".
15142888	Carcinogenesis	2004	Kim YH et al.	Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
21705428	Brain	2011	Gaub P et al.	The histone acetyltransferase p300 promotes intrinsic axonal regeneration.
21367844	Endocr. Relat. Cancer	2011	Dong X et al.	Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.
21383005	Mol. Cancer Res.	2011	Fan T et al.	EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
21224215	Am. J. Physiol. Lung Cell Mol. Physiol.	2011	Mizuno S et al.	Inhibition of histone deacetylase causes emphysema.
21209038	Carcinogenesis	2011	Nandakumar V et al.	(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
19211809	Biol. Reprod.	2009	Sakurai T et al.	Induction of endogenous interferon tau gene transcription by CDX2 and high acetylation in bovine nontrophoblast cells.
19223499	Clin. Cancer Res.	2009	Deng G et al.	Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
19755393	Clin. Cancer Res.	2009	Hirata H et al.	Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.
19737884	Invest. Ophthalmol. Vis. Sci.	2010	Kashiwagi Y et al.	Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
19700647	Am. J. Physiol. Lung Cell Mol. Physiol.	2009	Guo W et al.	Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.
19122173	Arterioscler. Thromb. Vasc. Biol.	2009	Dje N'Guessan P et al.	Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells.
19096014	Blood	2009	Hambach L et al.	Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
19458058	Clin. Cancer Res.	2009	Hauswald S et al.	Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes.
19505873	Mol. Cell Proteomics	2009	Ku WC et al.	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.
19509051	J. Cell. Sci.	2009	Chang J et al.	The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons.
19638401	FASEB J.	2009	Chandrasekaran S et al.	Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes.
19640900	Am. J. Physiol. Renal Physiol.	2009	Pang M et al.	Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
20404016	Exp. Biol. Med. (Maywood)	2010	Yang H et al.	Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells.
19864643	Blood	2009	Li X et al.	Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos.
19805123	Proc. Natl. Acad. Sci. U.S.A.	2009	Liberatore RA et al.	NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts.
19805354	Proc. Natl. Acad. Sci. U.S.A.	2009	Gibbs A et al.	Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6.
19808903	Mol. Cancer Res.	2009	Lee JH et al.	Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway.
20442303	Mol. Cancer Ther.	2010	Jeon HW and Lee YM	Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.
20304828	J. Immunol.	2010	Lu L et al.	Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells.
20622005	Carcinogenesis	2010	Ma J et al.	Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer.
20643785	Mol. Cancer Ther.	2010	Rahman R et al.	Histone deacetylase inhibition attenuates cell growth with associated telomerase inhibition in high-grade childhood brain tumor cells.
20547733	Cardiovasc. Res.	2010	Kaichi S et al.	Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice.
20118114	Hum. Reprod.	2010	Lu Y et al.	Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice.
20089874	Invest. Ophthalmol. Vis. Sci.	2010	Wang J et al.	Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing.
19966229	Proc. Natl. Acad. Sci. U.S.A.	2009	Cao Y et al.	Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models.
16816106	FASEB J.	2006	Aung HT et al.	LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression.
22065773	Proc. Natl. Acad. Sci. U.S.A.	2011	Matoba S et al.	RNAi-mediated knockdown of Xist can rescue the impaired postimplantation development of cloned mouse embryos.
21771882	J. Cell. Sci.	2011	Watanabe Y and Tanaka M	p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate.
17332375	Science	2007	Jung J and Bonini N	CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease.
17339403	J. Mol. Endocrinol.	2007	Jaffe RC et al.	Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression.
17339605	Mol. Cancer Res.	2007	Alimirah F et al.	IFI16 in human prostate cancer.
17307905	Reproduction	2007	Bui HT et al.	Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes.
17360565	Proc. Natl. Acad. Sci. U.S.A.	2007	Li B et al.	FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.
17392473	J. Neurosci.	2007	Dompierre JP et al.	Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.
17596302	J. Virol.	2007	Ye J et al.	De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
17507654	Mol. Biol. Cell	2007	Royo H et al.	Bsr, a nuclear-retained RNA with monoallelic expression.
17267518	Mol. Hum. Reprod.	2007	Nagashima T et al.	Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.
18024558	Plant Physiol.	2008	Tanaka M et al.	The Arabidopsis histone deacetylases HDA6 and HDA19 contribute to the repression of embryonic properties after germination.
18025290	Mol. Cancer Ther.	2007	Moiseeva EP et al.	Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.
18354085	J. Cell. Sci.	2008	Kimata Y et al.	Diminishing HDACs by drugs or mutations promotes normal or abnormal sister chromatid separation by affecting APC/C and adherin.
18310117	J. Exp. Biol.	2008	Jiang Y et al.	Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes.
18314483	Mol. Cancer Res.	2008	Kim M et al.	Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
18281366	Rheumatology (Oxford)	2008	Nakamura C et al.	Anti-arthritic effects of combined treatment with histone deacetylase inhibitor and low-intensity ultrasound in the presence of microbubbles in human rheumatoid synovial cells.
18424709	J. Immunol.	2008	Sebastián C et al.	Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells.
18403638	Mol. Cancer Res.	2008	Ko JM et al.	Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
15827334	Mol. Cancer Ther.	2005	Strait KA et al.	Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad.
15755876	Mol. Cancer Res.	2005	Hu J and Colburn NH	Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
16339075	Mol. Biol. Cell	2006	Nishiyama A et al.	Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin.
14976039	Blood	2004	Milhem M et al.	Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.
15026474	J. Natl. Cancer Inst.	2004	Knobbe CB et al.	Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas.
16293776	J. Endocrinol.	2005	Lee JH et al.	Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1.
16227397	Mol. Cancer Ther.	2005	Francia G et al.	Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents.
16210620	J. Immunol.	2005	Bai Y et al.	Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity.
15486319	Circ. Res.	2004	Alcendor RR et al.	Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
15695762	J. Exp. Biol.	2005	Zhao Y et al.	Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors.
14871945	Eukaryotic Cell	2004	García I et al.	Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors.
14871994	Clin. Cancer Res.	2004	Takai N et al.	Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
15867260	Clin. Cancer Res.	2005	Touma SE et al.	Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
16000561	Clin. Cancer Res.	2005	Sato N et al.	Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
16505096	Mol. Cancer Ther.	2006	Ostapkowicz A et al.	Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor.
16505122	Mol. Cancer Ther.	2006	Hellebrekers DM et al.	Angiostatic activity of DNA methyltransferase inhibitors.
16489177	J. Clin. Pathol.	2006	Song YF et al.	High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma.
16513842	Mol. Cancer Res.	2006	Rokhlin OW et al.	Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
16877702	Mol. Cancer Res.	2006	Gaymes TJ et al.	Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?
17121923	Mol. Cancer Ther.	2006	Dowdy SC et al.	Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells.
16551870	Clin. Cancer Res.	2006	Gagnon JF et al.	Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer.
16720720	J. Mol. Endocrinol.	2006	Nygård M et al.	Thyroid hormone-mediated negative transcriptional regulation of Necdin expression.
16687489	Mol. Cancer Res.	2006	Wischnewski F et al.	Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
16738306	Mol. Biol. Cell	2006	Cabrero JR et al.	Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.
16162661	Am. J. Physiol., Cell Physiol.	2006	Hwang DY and Ismail-Beigi F	Control of Glut1 promoter activity under basal conditions and in response to hyperosmolarity: role of Sp1.
16174862	Am. J. Physiol. Renal Physiol.	2006	Yu Z and Kone BC	Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells.
16203797	Clin. Cancer Res.	2005	Fang MZ et al.	Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.
16129885	J. Cell. Sci.	2005	Somech R et al.	The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation.
17172411	Mol. Cancer Ther.	2006	Lee JH et al.	Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.
17220171	Hum. Mol. Genet.	2007	Ting CH et al.	Stat5 constitutive activation rescues defects in spinal muscular atrophy.
17209135	Am. J. Physiol. Lung Cell Mol. Physiol.	2007	Kuang PP et al.	Activation of elastin transcription by transforming growth factor-beta in human lung fibroblasts.
18505930	Mol. Cancer Res.	2008	Pan J et al.	TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells.
18483381	Clin. Cancer Res.	2008	Egler V et al.	Histone deacetylase inhibition and blockade of the glycolytic pathway synergistically induce glioblastoma cell death.
18448484	Carcinogenesis	2008	Jensen TJ et al.	Epigenetic remodeling during arsenical-induced malignant transformation.
18606645	J. Immunol.	2008	Schmeck B et al.	Histone acetylation and flagellin are essential for Legionella pneumophila-induced cytokine expression.
18644983	Mol. Cancer Res.	2008	Liu PY et al.	Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
18156164	Development	2008	Yeh JR et al.	AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression.
22271820	J. Pharmacol. Exp. Ther.	2012	Zhang L et al.	Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.
22955928	Blood	2012	Sadoul K et al.	HDAC6 controls the kinetics of platelet activation.
22771823	Eukaryotic Cell	2012	Tong K et al.	Schizosaccharomyces pombe Hat1 (Kat1) is associated with Mis16 and is required for telomeric silencing.
22493143	J. Mol. Endocrinol.	2012	Ching LY et al.	Synergistic effect of p53 on TSA-induced stanniocalcin 1 expression in human nasopharyngeal carcinoma cells, CNE2.
22430918	J Mol Cell Biol	2012	Bar-Nur O et al.	Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives.
22693257	J. Lipid Res.	2012	Nunes MJ et al.	Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway.
22859492	Arterioscler. Thromb. Vasc. Biol.	2012	Colussi C et al.	P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins.
23440186	Proc. Natl. Acad. Sci. U.S.A.	2013	Yeo M et al.	Bisphenol A delays the perinatal chloride shift in cortical neurons by epigenetic effects on the Kcc2 promoter.
23814181	Mutagenesis	2013	Keuser B et al.	Influences of histone deacetylase inhibitors and resveratrol on DNA repair and chromatin compaction.
23591990	Hum. Mol. Genet.	2013	Oleksiewicz U et al.	Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines.
23287862	Blood	2013	Gao C et al.	Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.
23236151	Proc. Natl. Acad. Sci. U.S.A.	2012	McCullough SD et al.	Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes.
23341636	Proc. Natl. Acad. Sci. U.S.A.	2013	Zhou G et al.	HSV carrying WT REST establishes latency but reactivates only if the synthesis of REST is suppressed.
23318799	Antimicrob. Agents Chemother.	2013	Wilson DW et al.	Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
23188729	Invest. Ophthalmol. Vis. Sci.	2013	Li H et al.	Epigenetic regulation of CXCR4 expression by the ocular microenvironment.
23195070	Am. J. Physiol., Cell Physiol.	2013	Gill RK et al.	Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2.
23043075	Am. J. Physiol. Lung Cell Mol. Physiol.	2012	Yang Q et al.	Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation.
23729439	J. Immunol.	2013	Gao B et al.	Inhibition of histone deacetylase activity suppresses IFN-γ induction of tripartite motif 22 via CHIP-mediated proteasomal degradation of IRF-1.
24174668	J. Neurosci.	2013	Liesz A et al.	Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke.
23430957	Carcinogenesis	2013	Chen CQ et al.	Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases.
23880304	Carcinogenesis	2013	Sharma A et al.	Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells.
24307736	J. Immunol.	2014	Serrat N et al.	The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPβ.